OncoTherapy Science, Inc. (TYO:4564)
Japan · Delayed Price · Currency is JPY 21.00
+1.00 (5.00%)
At close: Mar 6, 2026
OncoTherapy Science Market Cap
OncoTherapy Science has a market cap or net worth of 7.91 billion as of March 6, 2026. Its market cap has increased by 11.99% in one year.
Market Cap
7.91B
Enterprise Value
5.72B
Revenue
784.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.00
Market Cap Chart
Since June 29, 2007, OncoTherapy Science's market cap has decreased from 13.84B to 7.91B, a decrease of -42.86%. That is a compound annual growth rate of -2.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.91B | 15.08% |
| Dec 30, 2025 | 6.87B | 1.20% |
| Dec 30, 2024 | 6.79B | 35.66% |
| Dec 29, 2023 | 5.01B | -50.03% |
| Dec 30, 2022 | 10.02B | -27.78% |
| Dec 30, 2021 | 13.87B | -31.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 8.62B |
| BrightPath Biotherapeutics | 8.30B |
| MEDINET | 8.00B |
| ADR120S | 7.76B |
| CellSource | 7.53B |
| Chiome Bioscience | 7.22B |
| Linical | 7.00B |
| PRISM BioLab Co.,LTD | 6.69B |